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Two common strategies to secure
a victory are available to a
traditional Sumo wrestler: his goal
is achieved if he can force his
opponent either to step out of the
combat arena or to touch the
ground with any body part other
than his feet. In cell biology, the
actions of the small ubiquitin-
related modifier SUMO appear to
be guided by a similar, but even
more flexible set of rules: covalent
attachment of SUMO to a protein
usually forces the modified target
to undergo a change in its
localization, its interactions with
other cellular components, its
stability or its enzymatic activity
[1,2]. By affecting the properties
of its targets in such ways, SUMO
contributes to the regulation of
numerous biological processes,
ranging from nuclear transport [3]
to signal transduction [4],
transcription [5] and genome
integrity [6]. 
New SUMO targets are being
identified almost by the day,
though elucidation of the biological
consequences of sumoylation lags
far behind the discovery of target
proteins. In fact, the mechanisms
by which SUMO changes the
properties of its targets are rarely
well understood on a molecular
basis. New work by Steinacher and
Schär [7], reported in this issue of
Current Biology, has now begun to
shed light on the mechanism of
SUMO function in one
particular case.
Human thymine-DNA
glycosylase (TDG) promotes DNA
base excision repair by
recognizing thymine (T) or uracil
(U) when mispaired with guanine
(G) in double-stranded DNA [8,9].
It cleaves the N-glycosidic bond
between the base and the sugar
backbone, thus releasing the
mismatched base and creating an
abasic (AP) site. This structure is
then processed by downstream
enzymes, which cleave the DNA
backbone and initiate restoration
SUMO Modification: Wrestling
with Protein Conformation
SUMO modification of human thymine-DNA glycosylase facilitates the
processing of base excision repair substrates by an unusual
mechanism: while leaving the catalytic center unaffected, it induces
product release by eliciting a conformational change in the enzyme.
Figure 1. Influence of SUMO modification on the catalytic activity of human TDG in vitro.
(A) Unmodified TDG (brown) displays a high affinity for its substrates, including G•T and
G•U mismatches in double-stranded DNA, but also for the reaction product, the AP site.
Its high affinity is due to the contribution of the amino-terminal domain to non-specific
DNA binding and allows the enzyme to process both G•U and G•T mismatches, but
also results in a near complete product inhibition due to a failure to release the AP site
after excision of the mismatched base. (B) SUMO modification of TDG induces a con-
formational change in the amino-terminal domain that reduces the overall affinity of the
enzyme for DNA. As a consequence, the G•T mismatch, which requires strong DNA
binding for recognition, is no longer processed. (C) In contrast to the G•T mismatch, the
less demanding G•U mismatch is processed despite a reduced affinity of sumoylated
TDG for DNA. Because of the reduction in affinity, however, product inhibition is abol-




























of the nucleotide. The reaction
intermediate, the AP site, is a
dangerous structure if left
unprotected, because its
uncontrolled processing could
have devastating effects on
genome integrity [10]. This notion
has sparked the hypothesis that
the strong affinity for the reaction
product displayed by many DNA
glycosylases may shield the AP
site until a displacement by the
downstream AP endonuclease is
guaranteed [11,12]. But while
strong product inhibition can
indeed provide the necessary
protection for the AP site, it also
invokes the need for a controlled
dissociation mechanism.
A role for SUMO in regulating
substrate release was first
proposed by Schär and coworkers
[13] when they identified human
TDG as an in vivo sumoylation
target. Attachment of SUMO to a
lysine residue in the carboxy-
terminal domain of TDG was
found to reduce its affinity for the
product AP site in vitro, thus
allowing turnover on a G•U
mismatch. At the same time,
processing of a G•T substrate,
which is bound with lower affinity
by unmodified TDG, was
completely abolished in the
sumoylated form of the enzyme,
again consistent with a reduction
in overall DNA binding affinity. 
Careful mechanistic analysis
has now provided evidence that
the basis for the observed change
in affinity and catalytic activity of
TDG is a direct effect of SUMO on
the conformation of the enzyme
(Figure 1). Using truncated
versions of TDG, Steinacher and
Schär [7] showed that the amino-
terminal domain contributes to
high-affinity, non-specific
interaction with double-stranded
DNA and is responsible for
product inhibition and lack of
turnover in the full-length protein.
Consistent with this notion,
processing of a G•T mismatch is
poor in the bacterial uracil-DNA
glycosylase MUG, which lacks the
regulatory amino- and carboxy-
terminal domains [14]. 
Intriguingly, sumoylated TDG
resembled an amino-terminally
truncated version with respect to
DNA binding and catalytic
properties, indicating that
attachment of SUMO to the
carboxy terminus of TDG modifies
the properties of the enzyme’s
amino-terminal domain. A direct
effect of sumoylation on the
structure of TDG’s amino
terminus was supported by an
analysis of protein conformation
using partial protease digests:
while the addition of DNA
sensitized unmodified TDG
toward proteolysis at a number of
sites, no DNA-dependent change
in the digestion pattern was
observed for the sumoylated
protein. 
These observations suggest
that unmodified, full-length TDG
adopts a different conformation
when bound to DNA, whereas a
similar change does not occur in
the SUMO-modified form.
Moreover, even in the absence of
DNA, protease digestion of
sumoylated TDG produced a
fragment of the amino-terminal
domain that was absent in
digests of the unmodified form,
implying that sumoylation of TDG
directly affects the conformation
of the amino terminus.
Without changing the
properties of the catalytic
domain, modulation of TDG’s
amino-terminal region by
sumoylation within the carboxyl
terminus thus provides for an
effective product-release
mechanism, which allows
catalytic turnover on more
demanding substrates, such as
the G•T mismatch (Figure 2).
Given that sumoylation has these
effects in an in vitro system,
modification of TDG is one of the
rare cases where SUMO directly
controls the properties of its
target, independently of its
interaction with other cellular
components or its subcellular
localization. This mode of action
stands in contrast to other well-
known examples of regulation by
sumoylation that mostly appear to
involve the creation of or
interference with protein–protein
interaction surfaces on the
modified target [2,4,5].
The model put forth here,
however, also raises a number of
important issues that need to be
resolved in order to understand
the function of TDG sumoylation
in its biological context. For one
thing, it postulates a cycle of
SUMO conjugation and
deconjugation for each catalytic
turnover on a G•T mismatch
(Figure 2), a plausible hypothesis
that is consistent with the
reversible and often transient
nature of SUMO modification [2,5]
and could in principle be tested
in vitro with the use of the
appropriate modifying and
deconjugating enzymes. 
Yet more important is the
question of whether the control of
product release by SUMO
actually contributes to the
shielding of the AP site for a
hand-over to downstream
enzymes. If this notion is valid, it
will be critical to determine the
factors that regulate the
modification reaction itself: if
sumoylation causes an immediate
dissociation of TDG from the AP
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Figure 2. Model for the
processing of a G•T
mismatch by TDG in vivo. 
Catalytic turnover on a G•T
mismatch could be achieved
by repeated cycles of
sumoylation and desumoy-
lation. This would entail suc-
cessive steps of high-affinity
substrate binding and base
excision by the unmodified
form, sumoylation of the
DNA-bound form and sub-
sequent release from the
product AP site. Once
released from the DNA, TDG
can be desumoylated by an
isopeptidase, and the next
reaction cycle can be initi-
ated. Coordination of the
sumoylation step with the binding of the downstream enzyme, AP endonuclease, would



















site, the modification must not
occur prior to the arrival of an AP
endonuclease at the site of
action. If sumoylation takes place
without the need for downstream
enzymes, dissociation of TDG
from the DNA in vivo must be
slowed down until protection of
the AP site is guaranteed. 
Takahashi et al. [15] recently
demonstrated that TDG is also
capable of interacting non-
covalently with SUMO, a property
shared by many other SUMO
targets, which is believed to serve
as a ‘molecular glue’ to facilitate
the assembly of multi-protein
complexes [2,4–6]. As the SUMO
interaction motif on TDG is
situated adjacent to the modified
lysine in the carboxy-terminal
domain [15], it is unlikely to
contribute to the observed
conformational changes in an
intramolecular fashion. Instead,
non-covalent interaction with
SUMO was shown to control the
protein’s subcellular localization
to PML nuclear bodies, thus
suggesting one of the more
conventional strategies available
to SUMO to exert its regulatory
power over its targets.
Nevertheless, even its influence
on TDG’s conformation is
somewhat reminiscent of a true
Sumo wrestler: according to a
less frequently applied rule of the
game, a bout is won when the
opponent’s mawashi, the
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Mitosis is the process of
chromosome separation that
precedes cytokinesis. During
mitosis in a eukaryotic cell, the
mitotic spindle microtubules are
connected to chromosomes via a
kinetochore, a protein complex
that bridges the centromeric
sequences on the DNA with the
spindle. Prokaryotes also need to
segregate their chromosomes in
order to produce viable progeny
cells; however, no mitotic spindle
equivalent has been found in
bacteria, perhaps because
bacterial cells often have just two
daughter chromosomes to
separate, and the separation
distance is much shorter. No
evidence for a bacterial
kinetochore has been found
either — until now.
In the original model for bacterial
chromosome segregation,
chromosomes were thought to be
attached to the cell membrane and
to be segregated passively, as a
result of cell elongation [1]. Two
breakthroughs led to revision of
this model. The first was the
discovery that chromosomal origin
(oriC) regions move toward the cell
poles much more rapidly than one
would expect were their separation
driven just by cell growth,
implicating an active partitioning
machine [2]. The second was the
discovery of prokaryotic homologs
of tubulin and actin. In a curious
reversal of functions, the tubulin
homolog is required for bacterial
cytokinesis but not mitosis, while
one of several actin homologs has
been implicated in chromosome
segregation. This actin homolog,
MreB, is strikingly similar to actin
both in molecular structure and in
its ability to assemble into ATP-
dependent filaments [3,4].
In the bacterial cell, MreB
forms a membrane-associated
coiled structure that often
extends along much of the cell
length [5]. Depletion of MreB in
rod-shaped bacilli such as
Escherichia coli and Bacillus
subtilis, or crescent-shaped
Caulobacter crescentus, causes
the cells to lose their
characteristic shape. Additional
Bacterial Mitosis: Actin in a New
Role at the Origin
MreB is a prokaryotic homolog of actin involved in cellular organization
and chromosome segregation. Recent results suggest that MreB is
part of a kinetochore-like complex that specifically segregates the
replication origin region of the bacterial chromosome.
